The Effects of Passive Heat Therapy in Patients With Chronic Kidney Disease
NCT ID: NCT05924919
Last Updated: 2024-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2023-09-18
2024-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heat Therapy, Functional Capacity, and Vascular Health in Older Adults
NCT05706181
Effects of Passive Heat Therapy on Oxygen Consumption and Cardiovascular Fitness in Adults
NCT04026126
Chronic Passive Heating in Healthy Older Adults
NCT05618197
To Evaluate the Effects of Heating Device (Electronic Moxibustion) in Patients With Intradialytic Hypotension
NCT03856151
Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling
NCT05601713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Arm: Whole-body Passive Heat Therapy (HT)
Heat therapy will be administered using an infrared sauna. The intervention duration will last 25 minutes at a temperature of 60°C.
Whole-body Passive Heat Therapy (HT)
The whole-body passive heat therapy (HT) intervention will consist of an acute bout of infrared sauna for 25 minutes at 60°C. Participants will lie supine on a memory foam pad.
Thermoneutral Control (CON)
Participants will remain in a room temperature environment (22°C) underneath the infrared domes for 25 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole-body Passive Heat Therapy (HT)
The whole-body passive heat therapy (HT) intervention will consist of an acute bout of infrared sauna for 25 minutes at 60°C. Participants will lie supine on a memory foam pad.
Thermoneutral Control (CON)
Participants will remain in a room temperature environment (22°C) underneath the infrared domes for 25 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stage 2-4 CKD
Exclusion Criteria
* Uncontrolled hypertension
* Current fluid restrictions
* End stage kidney disease or currently on dialysis treatment
* Body weight \< 40kg
* Exhibits any contraindications to exercise as per ACSM guidelines
* Regular tobacco and/or nicotine use
* History of heat-related illness
* Participates in regular exercise and/or sauna use
* Current hormone replacement therapy
* Pacemaker or electro-medical implant
* Persons with or at risk of intestinal disorders including gastroporesis
* History of diverticula
* Persons who have undergone surgical procedures in the GI tract
* Swallowing disorders
* Chron's disease
* Current pregnancy
* Inability to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Kirkman, PhD
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-01741
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HM20024906
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.